Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukakecho, Toyoake 4701192, Japan.
Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.
Card Electrophysiol Clin. 2021 Mar;13(1):25-35. doi: 10.1016/j.ccep.2020.11.002.
Inflammation and fibrosis have been implicated in the pathophysiology of atrial fibrillation. Atrial fibrosis causes conduction disturbances and is a central component of atrial remodeling in atrial fibrillation. Cardiac fibroblasts, the cells responsible for fibrosis formation, are activated by inflammatory mediators and growth factors associated with systemic inflammatory conditions. Thus, inflammation contributes to atrial fibrosis; the complex interplay of these maladaptive components creates a vicious cycle of atrial remodeling progression, maintaining atrial fibrillation and increasing thrombogenicity. This review provides up-to-date knowledge regarding inflammation and fibrosis in atrial fibrillation pathophysiology and their potential as therapeutic targets.
炎症和纤维化与心房颤动的病理生理学有关。心房纤维化导致传导障碍,是心房颤动中心房重构的一个重要组成部分。心肌成纤维细胞是形成纤维化的细胞,它受与全身炎症状态相关的炎症介质和生长因子的激活。因此,炎症导致心房纤维化;这些适应性不良成分的复杂相互作用产生了心房重构进展的恶性循环,维持心房颤动并增加血栓形成。这篇综述提供了关于心房颤动病理生理学中炎症和纤维化的最新知识,以及它们作为治疗靶点的潜力。